史丹利(002588.SZ)第三季度淨利潤預增6.25%
格隆匯10月13日丨史丹利(002588.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨利潤3.468億元,同比增長70.03%;其中,第三季度歸屬於上市公司股東的淨利潤6991.34萬元,同比增長6.25%。業績變動原因如下:
1、報吿期公司的產品單位毛利較同期實現了小幅上漲,公司充分利用資金優勢做好原材料戰略採購,並根據原材料上漲及下游需求情況進行了多次產品價格調整,確保了產品的毛利空間,帶來了毛利額的增長。
2、公司深化管理強度,加強了費用的合理管控,同時注重資金管理,貨幣資金較同期增加,從而實現理財利息收入的大幅增加,提高了營業利潤。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.